Citigroup Inc. Grows Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

Citigroup Inc. increased its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 7.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 192,768 shares of the health services provider's stock after acquiring an additional 12,911 shares during the period. Citigroup Inc. owned approximately 0.59% of Amedisys worth $18,604,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Charles Schwab Investment Management Inc. boosted its stake in Amedisys by 2.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider's stock worth $33,400,000 after acquiring an additional 9,004 shares in the last quarter. Amara Financial LLC. bought a new stake in Amedisys during the third quarter worth about $526,000. KBC Group NV bought a new stake in Amedisys during the third quarter worth about $63,000. State of New Jersey Common Pension Fund D boosted its stake in Amedisys by 1.7% during the third quarter. State of New Jersey Common Pension Fund D now owns 20,357 shares of the health services provider's stock worth $1,965,000 after acquiring an additional 339 shares in the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in shares of Amedisys in the third quarter worth approximately $243,000. Institutional investors own 94.36% of the company's stock.

Amedisys Stock Up 0.2 %

Shares of NASDAQ AMED traded up $0.21 during midday trading on Wednesday, hitting $91.23. The stock had a trading volume of 113,954 shares, compared to its average volume of 358,200. The business's 50 day moving average is $95.10 and its 200-day moving average is $95.71. The company has a market cap of $2.99 billion, a P/E ratio of 36.22, a PEG ratio of 1.91 and a beta of 0.78. Amedisys, Inc. has a 52 week low of $88.81 and a 52 week high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.98 EPS. As a group, analysts predict that Amedisys, Inc. will post 4.55 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.